Cargando…

Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model

BACKGROUND AND AIM: Anti-sperm antibodies (ASAs) treatment continued to be neglected. This study aimed to generate ASAs using the testicular sperm aspiration (TSA) rat model, which allowed for investigation of four distinct therapeutic approaches to find potential treatments for ASAs. MATERIALS AND...

Descripción completa

Detalles Bibliográficos
Autores principales: Zaki, Abdel-Kader A., Aldahmashi, Fahad S., Madboli, Abd El-Nasser A., Attia, Kamal A., Almulhim, Fahad S., Albarrak, Saleh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Veterinary World 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082712/
https://www.ncbi.nlm.nih.gov/pubmed/37042009
http://dx.doi.org/10.14202/vetworld.2023.296-308
_version_ 1785021367281778688
author Zaki, Abdel-Kader A.
Aldahmashi, Fahad S.
Madboli, Abd El-Nasser A.
Attia, Kamal A.
Almulhim, Fahad S.
Albarrak, Saleh M.
author_facet Zaki, Abdel-Kader A.
Aldahmashi, Fahad S.
Madboli, Abd El-Nasser A.
Attia, Kamal A.
Almulhim, Fahad S.
Albarrak, Saleh M.
author_sort Zaki, Abdel-Kader A.
collection PubMed
description BACKGROUND AND AIM: Anti-sperm antibodies (ASAs) treatment continued to be neglected. This study aimed to generate ASAs using the testicular sperm aspiration (TSA) rat model, which allowed for investigation of four distinct therapeutic approaches to find potential treatments for ASAs. MATERIALS AND METHODS: Adult Wistar albino male rats were divided into six equal groups (n = 12). The negative control group underwent scrotal sac surgery without having their testicles punctured. Punctures were made in the remaining 5 groups, with one group left untreated to serve as the positive control group. The remaining 4 groups were treated with either dexamethasone (DEX), azathioprine (AZA), frankincense, or anti-ASAs secondary antibodies. For 10 weeks, serum samples were collected every 2 weeks for specific quantification of ASAs. Testis and epididymis tissues were collected for histopathological analysis. RESULTS: The ASAs concentrations of the positive controls were significantly higher (p ≤ 0.001) than their negative control counterparts during the examined weeks. However, The ASAs indices (%) differed according to the treatment type. While the ASAs indices at the 2(nd) and 4(th) weeks in the AZA-treated group were significantly reduced compared to the positive control group (p ≤ 0.001), no significant differences were observed at any of the sample collection week for the DEX-treated rats. The ASAs indices were significantly decreased only at weeks 6 and 8 of treatment in the frankincense-treated group (p ≤ 0.001). In the secondary antibodies-treated group, the antibody indices were significantly decreased in all weeks except for samples collected at week 4 (p ≤ 0.001). The testosterone levels reverted to normal only in TSA rats treated with either Frankincense or secondary antibodies, as they were significantly higher than the positive controls (p ≤ 0.05). Tissue samples from the secondary antibody-treated rats showed a generally normal histological appearance. CONCLUSION: This study tried to offer realistic therapy suggestions; however, caution should be applied when extrapolating findings from experimental models to meet clinical requirements.
format Online
Article
Text
id pubmed-10082712
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Veterinary World
record_format MEDLINE/PubMed
spelling pubmed-100827122023-04-10 Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model Zaki, Abdel-Kader A. Aldahmashi, Fahad S. Madboli, Abd El-Nasser A. Attia, Kamal A. Almulhim, Fahad S. Albarrak, Saleh M. Vet World Research Article BACKGROUND AND AIM: Anti-sperm antibodies (ASAs) treatment continued to be neglected. This study aimed to generate ASAs using the testicular sperm aspiration (TSA) rat model, which allowed for investigation of four distinct therapeutic approaches to find potential treatments for ASAs. MATERIALS AND METHODS: Adult Wistar albino male rats were divided into six equal groups (n = 12). The negative control group underwent scrotal sac surgery without having their testicles punctured. Punctures were made in the remaining 5 groups, with one group left untreated to serve as the positive control group. The remaining 4 groups were treated with either dexamethasone (DEX), azathioprine (AZA), frankincense, or anti-ASAs secondary antibodies. For 10 weeks, serum samples were collected every 2 weeks for specific quantification of ASAs. Testis and epididymis tissues were collected for histopathological analysis. RESULTS: The ASAs concentrations of the positive controls were significantly higher (p ≤ 0.001) than their negative control counterparts during the examined weeks. However, The ASAs indices (%) differed according to the treatment type. While the ASAs indices at the 2(nd) and 4(th) weeks in the AZA-treated group were significantly reduced compared to the positive control group (p ≤ 0.001), no significant differences were observed at any of the sample collection week for the DEX-treated rats. The ASAs indices were significantly decreased only at weeks 6 and 8 of treatment in the frankincense-treated group (p ≤ 0.001). In the secondary antibodies-treated group, the antibody indices were significantly decreased in all weeks except for samples collected at week 4 (p ≤ 0.001). The testosterone levels reverted to normal only in TSA rats treated with either Frankincense or secondary antibodies, as they were significantly higher than the positive controls (p ≤ 0.05). Tissue samples from the secondary antibody-treated rats showed a generally normal histological appearance. CONCLUSION: This study tried to offer realistic therapy suggestions; however, caution should be applied when extrapolating findings from experimental models to meet clinical requirements. Veterinary World 2023-02 2023-02-15 /pmc/articles/PMC10082712/ /pubmed/37042009 http://dx.doi.org/10.14202/vetworld.2023.296-308 Text en Copyright: © Zaki, et al. https://creativecommons.org/licenses/by/4.0/Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) ), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zaki, Abdel-Kader A.
Aldahmashi, Fahad S.
Madboli, Abd El-Nasser A.
Attia, Kamal A.
Almulhim, Fahad S.
Albarrak, Saleh M.
Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title_full Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title_fullStr Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title_full_unstemmed Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title_short Therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
title_sort therapeutic approaches for anti-sperm-antibodies in the testicular sperm aspiration rat model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10082712/
https://www.ncbi.nlm.nih.gov/pubmed/37042009
http://dx.doi.org/10.14202/vetworld.2023.296-308
work_keys_str_mv AT zakiabdelkadera therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel
AT aldahmashifahads therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel
AT madboliabdelnassera therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel
AT attiakamala therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel
AT almulhimfahads therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel
AT albarraksalehm therapeuticapproachesforantispermantibodiesinthetesticularspermaspirationratmodel